Selectis Health, Inc.
GBCS
$2.20
-$0.05-2.22%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 480.20K | 639.10K | 637.00K | 634.50K | 597.50K |
| Total Other Revenue | 37.82M | 36.69M | 36.03M | 36.15M | 37.78M |
| Total Revenue | 38.30M | 37.33M | 36.67M | 36.78M | 38.38M |
| Cost of Revenue | 30.23M | 30.36M | 30.37M | 31.38M | 32.30M |
| Gross Profit | 8.06M | 6.97M | 6.30M | 5.41M | 6.08M |
| SG&A Expenses | 12.05M | 12.21M | 12.34M | 12.70M | 11.80M |
| Depreciation & Amortization | 1.64M | 1.62M | 1.65M | 1.67M | 1.68M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 43.92M | 44.19M | 44.36M | 45.74M | 45.78M |
| Operating Income | -5.63M | -6.87M | -7.69M | -8.96M | -7.40M |
| Income Before Tax | -5.48M | -6.14M | -9.03M | -3.97M | -2.53M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.48 | -6.14 | -9.03 | -3.97 | -2.53 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.48M | -6.14M | -9.03M | -3.97M | -2.53M |
| EBIT | -5.63M | -6.87M | -7.69M | -8.96M | -7.40M |
| EBITDA | -3.99M | -5.25M | -6.04M | -7.29M | -5.72M |
| EPS Basic | -1.80 | -2.02 | -2.96 | -1.31 | -0.84 |
| Normalized Basic EPS | -1.55 | -1.79 | -1.95 | -2.23 | -1.93 |
| EPS Diluted | -1.80 | -2.02 | -2.97 | -1.31 | -0.84 |
| Normalized Diluted EPS | -1.55 | -1.79 | -1.95 | -2.23 | -1.93 |
| Average Basic Shares Outstanding | 12.26M | 12.24M | 12.23M | 12.22M | 12.22M |
| Average Diluted Shares Outstanding | 12.26M | 12.24M | 12.23M | 12.22M | 12.22M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.00% | 0.00% | 0.00% | -0.17% | -0.57% |
